Recurrent acute otitis media : a survey of current management in England
OBJECTIVE: Recurrent acute otitis media is common in children. The preferred treatment measures for recurrent acute otitis media have a mixed evidence base. This study sought to assess baseline practice across ENT departments in England.
METHODS: A national telephone survey of healthcare staff was conducted. Every ENT centre in England was contacted. A telephone script was used to ask about antibiotic and grommet use and duration in recurrent acute otitis media cases.
RESULTS: Ninety-six centres (74 per cent) provided complete information. Recurrent acute otitis media treatment across England by ENT departments varied. The antibiotic first- and second-line prophylaxis offered varies, with trimethoprim used in 33 centres and 29 centres not offering any antibiotics. The timing or choice about when to use grommets also varies, but 87 centres (91 per cent) offer grommet surgery at one stage.
CONCLUSION: The treatments received by children in England for recurrent acute otitis media vary by centre; collaborative research in this area is advised.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:135 |
---|---|
Enthalten in: |
The Journal of laryngology and otology - 135(2021), 10 vom: 15. Okt., Seite 855-857 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hampton, T [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 30.09.2021 Date Revised 30.09.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1017/S0022215121001924 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330195409 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330195409 | ||
003 | DE-627 | ||
005 | 20231225210750.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1017/S0022215121001924 |2 doi | |
028 | 5 | 2 | |a pubmed24n1100.xml |
035 | |a (DE-627)NLM330195409 | ||
035 | |a (NLM)34477050 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hampton, T |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recurrent acute otitis media |b a survey of current management in England |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.09.2021 | ||
500 | |a Date Revised 30.09.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: Recurrent acute otitis media is common in children. The preferred treatment measures for recurrent acute otitis media have a mixed evidence base. This study sought to assess baseline practice across ENT departments in England | ||
520 | |a METHODS: A national telephone survey of healthcare staff was conducted. Every ENT centre in England was contacted. A telephone script was used to ask about antibiotic and grommet use and duration in recurrent acute otitis media cases | ||
520 | |a RESULTS: Ninety-six centres (74 per cent) provided complete information. Recurrent acute otitis media treatment across England by ENT departments varied. The antibiotic first- and second-line prophylaxis offered varies, with trimethoprim used in 33 centres and 29 centres not offering any antibiotics. The timing or choice about when to use grommets also varies, but 87 centres (91 per cent) offer grommet surgery at one stage | ||
520 | |a CONCLUSION: The treatments received by children in England for recurrent acute otitis media vary by centre; collaborative research in this area is advised | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Bacterial | |
650 | 4 | |a Child | |
650 | 4 | |a Chronic Disease | |
650 | 4 | |a Drug Resistance | |
650 | 4 | |a Otitis Media | |
650 | 4 | |a Otolaryngology | |
650 | 4 | |a Questionnaires | |
650 | 4 | |a Surveys | |
650 | 4 | |a Trimethoprim | |
650 | 4 | |a United Kingdom | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Anti-Infective Agents, Urinary |2 NLM | |
650 | 7 | |a Trimethoprim |2 NLM | |
650 | 7 | |a AN164J8Y0X |2 NLM | |
700 | 1 | |a Whitehall, E |e verfasserin |4 aut | |
700 | 1 | |a Beasley, C |e verfasserin |4 aut | |
700 | 1 | |a Stevens, K |e verfasserin |4 aut | |
700 | 1 | |a Lowe, N |e verfasserin |4 aut | |
700 | 1 | |a Hogg, E |e verfasserin |4 aut | |
700 | 1 | |a Bhat, J |e verfasserin |4 aut | |
700 | 1 | |a Emerson, H |e verfasserin |4 aut | |
700 | 1 | |a Krishnan, M |e verfasserin |4 aut | |
700 | 1 | |a Sharma, S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of laryngology and otology |d 1945 |g 135(2021), 10 vom: 15. Okt., Seite 855-857 |w (DE-627)NLM000061794 |x 1748-5460 |7 nnns |
773 | 1 | 8 | |g volume:135 |g year:2021 |g number:10 |g day:15 |g month:10 |g pages:855-857 |
856 | 4 | 0 | |u http://dx.doi.org/10.1017/S0022215121001924 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 135 |j 2021 |e 10 |b 15 |c 10 |h 855-857 |